美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA209371"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
59651-025-75 59651-025 HUMAN PRESCRIPTION DRUG Amoxicillin and Clavulanate Potassium Amoxicillin and Clavulanate Potassium POWDER, FOR SUSPENSION ORAL 20190419 N/A ANDA ANDA209371 Aurobindo Pharma Limited AMOXICILLIN; CLAVULANATE POTASSIUM 125 mg/5mL; 31.25 mg/5mL 75 mL in 1 BOTTLE (59651-025-75)
59651-025-55 59651-025 HUMAN PRESCRIPTION DRUG Amoxicillin and Clavulanate Potassium Amoxicillin and Clavulanate Potassium POWDER, FOR SUSPENSION ORAL 20190419 N/A ANDA ANDA209371 Aurobindo Pharma Limited AMOXICILLIN; CLAVULANATE POTASSIUM 125 mg/5mL; 31.25 mg/5mL 150 mL in 1 BOTTLE (59651-025-55)
59651-025-01 59651-025 HUMAN PRESCRIPTION DRUG Amoxicillin and Clavulanate Potassium Amoxicillin and Clavulanate Potassium POWDER, FOR SUSPENSION ORAL 20190419 N/A ANDA ANDA209371 Aurobindo Pharma Limited AMOXICILLIN; CLAVULANATE POTASSIUM 125 mg/5mL; 31.25 mg/5mL 100 mL in 1 BOTTLE (59651-025-01)
59651-026-01 59651-026 HUMAN PRESCRIPTION DRUG Amoxicillin and Clavulanate Potassium Amoxicillin and Clavulanate Potassium POWDER, FOR SUSPENSION ORAL 20190419 N/A ANDA ANDA209371 Aurobindo Pharma Limited AMOXICILLIN; CLAVULANATE POTASSIUM 250 mg/5mL; 62.5 mg/5mL 100 mL in 1 BOTTLE (59651-026-01)
59651-026-55 59651-026 HUMAN PRESCRIPTION DRUG Amoxicillin and Clavulanate Potassium Amoxicillin and Clavulanate Potassium POWDER, FOR SUSPENSION ORAL 20190419 N/A ANDA ANDA209371 Aurobindo Pharma Limited AMOXICILLIN; CLAVULANATE POTASSIUM 250 mg/5mL; 62.5 mg/5mL 150 mL in 1 BOTTLE (59651-026-55)
59651-026-75 59651-026 HUMAN PRESCRIPTION DRUG Amoxicillin and Clavulanate Potassium Amoxicillin and Clavulanate Potassium POWDER, FOR SUSPENSION ORAL 20190419 N/A ANDA ANDA209371 Aurobindo Pharma Limited AMOXICILLIN; CLAVULANATE POTASSIUM 250 mg/5mL; 62.5 mg/5mL 75 mL in 1 BOTTLE (59651-026-75)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase